These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4349930)

  • 1. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamic effect of alkylating cytostatics].
    Maass H
    Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts on the interference of alkylating antitumor agents with the regulation of cell division.
    Grunicke H; Gantner G; Holzweber F; Ihlenfeldt M; Puschendorf B
    Adv Enzyme Regul; 1978; 17():291-305. PubMed ID: 757312
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of irradiation and alkylating agents on chromatin breakdown in normal and malignant lymphoid cells].
    Riabchenko NI; Jurasková V; Ivannik BP; Konov AV; Drasil V
    Radiobiologiia; 1991; 31(1):22-6. PubMed ID: 2008520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of urethan with macromolecules in male and female newborn, adult, and tumor-bearing mice.
    Chavon BG; Bhide SV
    J Natl Cancer Inst; 1972 Oct; 49(4):1019-25. PubMed ID: 5084120
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relaxation of DNA-protein interactions in mouse lymphoblastic leukemic cells exposed to antineoplastic agents].
    Serebrianyĭ AM; S'iakste NI; Gorin AI; Tseĭtlin PI; Bogomolova NS
    Biull Eksp Biol Med; 1983 Sep; 96(9):84-6. PubMed ID: 6577919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different uptake of two alkylating substances by ascites tumor cells.
    Schmidt H; Liss E
    Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of antineoplastic drugs on blood and tumor water-electrolyte balance in mice and rats].
    Pashinskiĭ BG
    Vopr Onkol; 1969; 15(6):65-8. PubMed ID: 5820355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of "coplanar hetero-oligobases" on the metabolism of nucleic acids and nucleotide in Ehrlich ascites cells].
    Schneider F; Warnecke P; Härlin R
    Arzneimittelforschung; 1970 Dec; 20(12):1942-5. PubMed ID: 5537104
    [No Abstract]   [Full Text] [Related]  

  • 14. Different degradation rates of alkylated RNA protein and lipids in normal and tumor cells.
    Lerman MI; Abakumova OY; Kucenco NG; Gorbacheva LB; Kukushkina GV; Serebryanyi AM
    Cancer Res; 1974 Jul; 34(7):1536-41. PubMed ID: 4365228
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical method of screening of microbial products exhibiting antitumor activity.
    Nitta K; Mizuno S; Umezawa H
    J Antibiot (Tokyo); 1966 Nov; 19(6):282-4. PubMed ID: 6013239
    [No Abstract]   [Full Text] [Related]  

  • 16. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory action of retinoic acid and N-(4-carboxyphenyl)-retinamide on the biosynthesis of DNA, RNA and protein in Ehrlich ascites carcinoma].
    Song ZP; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):418-20. PubMed ID: 6242543
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis.
    DiStefano JF; Lysik R; Zucker S
    Cancer Res; 1979 Apr; 39(4):1193-8. PubMed ID: 421203
    [No Abstract]   [Full Text] [Related]  

  • 19. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
    Fedorov NA; Matveenko VN; Tikhonova EF
    Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumor biochemistry as basis for advances in tumor chemotherapy].
    Grunicke H; Doppler W; Helliger W; Hermann BJ; Hofmann J; Lindner H; Puschendorf B
    Arch Geschwulstforsch; 1986; 56(3):193-201. PubMed ID: 3488047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.